莱多斯
LDOS
124.85
+0.85
+0.69%
莱多斯
US · LDOS
#1114 按市值排名
上市于 1970
124.85
+0.85
+0.69%
实时 - 追踪5344个代码 - 心跳于500秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
增持
- 最近一期（2026/Q3）披露持股的机构数量减少了2家。
- 机构持股总比例上升了1.1个百分点。
机构持股
- 机构持股比例
- 82.13% +1.13pp
- 机构数量
- 936 -2
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向分歧机构在上一报告期增持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向出现分歧。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund68.92%
Hedge Fund3.77%
Public Company3.40%
Private Company2.31%
Government Pension Fund1.46%
Sovereign Wealth Fund1.41%
Individual/Insider0.65%
Family Office/Trust0.35%
Insurance Company0.21%
Other17.52%
主要股东 截至 2026-06-30
BlackRock
7.93% · 9.95M 股
Vanguard Capital Management, LLC
7.11% · 8.92M 股
State Street Global Advisors
5.00% · 6.28M 股
Vanguard Portfolio Management, LLC
4.28% · 5.37M 股
Geode Capital Management, LLC
2.93% · 3.67M 股
J.P. Morgan Asset Management, Inc.
2.79% · 3.50M 股
Invesco Capital Management LLC
2.25% · 2.82M 股
First Trust Advisors L.P.
2.21% · 2.78M 股
Dimensional Fund Advisors
1.69% · 2.13M 股
Van Eck Associates Corporation
1.61% · 2.02M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 38次买入 · 12次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Gerard Fasano | Group President of Defense Group | 0.08% |
| Harry M. Kraemer | Independent Director | 0.07% |
| Noel Geer | Independent Director | 0.05% |
| Mary Schmanske | Executive VP of Corporate Operations & Chief Corporate Operations Officer | 0.05% |
| Robert Shapard | Independent Chairperson | 0.05% |
| Christopher Cage | Chief Financial Officer | 0.05% |
| Roy Stevens | President of the Intelligence Group | 0.04% |
| Thomas Bell | Chief Executive Officer | 0.04% |
| Elizabeth A. Porter | President of Health Group | 0.04% |
| Steve Hull | Former Chief Information Officer | 0.03% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-29 | Robert Shapard | Independent Chairperson | Other Acquisition | +5 | -- |
| 2026-09-29 | Harry M. Kraemer | Independent Director | Other Acquisition | +463 | -- |
| 2026-09-29 | Daniel Antal | Former Corporate Secretary | Other Acquisition | +4 | -- |
| 2026-09-29 | Roy Stevens | President of the Intelligence Group | Other Acquisition | +6 | -- |
| 2026-09-29 | Christopher Cage | Chief Financial Officer | Other Acquisition | +92 | -- |
| 2026-08-31 | Gary May | Independent Director | Open Market Disposition | -1,000 | $140.85 |
| 2026-08-10 | Noel Geer | Independent Director | Open Market Disposition | -10,000 | $140.59–141.07 |
| 2026-08-03 | Roy Stevens | President of the Intelligence Group | Sale to Issuer | -4,584 | $118.72 |
| 2026-08-03 | Christopher Cage | Chief Financial Officer | Sale to Issuer | -4,584 | $118.72 |
| 2026-08-03 | Elizabeth A. Porter | President of Health Group | Sale to Issuer | -5,092 | $118.72 |
| 2026-07-05 | Harry M. Kraemer | Independent Director | Other Acquisition | +310 | -- |
| 2026-06-29 | Robert Shapard | Independent Chairperson | Other Acquisition | +6 | -- |
| 2026-06-29 | Harry M. Kraemer | Independent Director | Other Acquisition | +565 | -- |
| 2026-06-29 | Daniel Antal | Former Corporate Secretary | Other Acquisition | +5 | -- |
| 2026-06-29 | Roy Stevens | President of the Intelligence Group | Other Acquisition | +7 | -- |
| 2026-06-29 | Christopher Cage | Chief Financial Officer | Other Acquisition | +113 | -- |
| 2026-05-07 | Noel Geer | Independent Director | Other Acquisition | +1,067 | -- |
| 2026-05-07 | Noel Geer | Independent Director | Other Derivative Acquisition | +1,281 | $131.26 |
| 2026-05-07 | Robert Shapard | Independent Chairperson | Other Acquisition | +1,067 | -- |
| 2026-05-07 | Robert Shapard | Independent Chairperson | Other Derivative Acquisition | +1,281 | $131.26 |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:05 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
莱多斯 讨论区 0 条评论